Skip to main content
FinSpry Logo
FinSpry
EVH logo
EVH
(NYSE)
Evolent Health, Inc.
$4.15-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Evolent Health, Inc. (EVH) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Evolent Health, Inc. stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Buy
Based on 9 unique analysts
(10 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$5.80
↑ 39.76% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest EVH Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Edmund Ingham
Forbes
BuyInitiates Coverage
-
Ryan Daniels
William Blair
BuyReiterates
-
Sean Dodge
BMO Capital
BuyMaintains
$6.00
Matthew Shea
Needham
BuyReiterates
$5.00
Ryan Halsted
RBC Capital
HoldMaintains
$3.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
David Larsen
BTIG
BuyInitiates Coverage
$8.00
Urmimala Biswas
Zacks Equity Research
BuyInitiates Coverage
-
Jailendra Singh
Truist
HoldDowngrades
$7.00
Jailendra Singh
Truist
BuyMaintains
$6.00 → $7.00

Frequently Asked Questions

What is the analyst consensus rating for EVH?

The analyst consensus rating for EVH is "Buy" based on 9 analyst recommendations.

What is the average price target for EVH?

The average 12-month price target for EVH is $5.80, representing an upside of 39.8% from the current price of $4.15.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.